Avandamet diabetes drug

Avandamet diabetes drug

C007/2559 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.3MB

Downloadable file size: 1.3MB

Price image Pricing

Please login to use the price calculator


Credit: MARK THOMAS/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only

Caption: Avandamet diabetes drug packaging and tablets. This drug, which contains the active ingredients rosiglitazone and metformin, is used to treat type II diabetes. It controls blood sugar levels by reducing the production and secretion of glucose by the liver and increasing the body's sensitivity to insulin, the hormone that regulates blood glucose levels. Avandamet requires that some insulin is produced by the pancreas and so cannot be used to treat type I diabetes. Rosiglitazone has been linked to an increased risk of heart attacks and heart failure.

Release details: Model release not required. Property release not available.

Keywords: 2 milligrams, 2mg, anti-diabetic, antihyperglycemic agent, avandamet, avandia, biguanide, blood glucose level, blood sugar level, box, dangerous, diabetes mellitus, drug, glaxosmithkline, gsk, heart attack, heart failure, insulin sensitiser, medical, medicine, metformin, packaging, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, rosiglitazone, still life, still-life, tablet, tablets, thiazolidinedione, treatment, type 2, type ii

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.